Here are relevant reports on : ai-in-medical-simulation-market
-
Medical Simulation Software Market by Offering (Virtual Anatomy, Surgical Simulation (Robotic, Ortho, Endo, Optha), Procedural, Radiation, Diagnostic), Technology (VR, AR, AI), End User (Hospitals, Academic Institutes, Military) - Global Forecast to 2030
The Medical Simulation Software market, valued at USD 0.18 billion in 2024, stood at USD 0.21 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2030, culminating in a forecasted valuation of USD 0.46 billion by the end of the period. The medical simulation market is expanding due to the increasing complexity of medical procedures and the growing emphasis on competency-based clinical training.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Medical Immersive Simulation Market by Tech (VR, AR, Haptics VR, AI), Offering (Hardware, Software, Services), Application (Medical, Procedural, Surgery, Emergency, Anatomy, Diagnostic), End User (Academic Institutes, Hospitals) - Global Forecast to 2030
The global medical immersive simulation market is projected to reach USD 1.37 billion by 2030, growing at a CAGR of 12.3% during the forecast period (2025–2030). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
AI in Chemicals Market by Hardware (Accelerators, Processors, Memory, Network), Software (Dashboard & Analytics, Process Simulation, Laboratory Management, Chemical Property Prediction, Virtual Screening), Technology (ML, NLP) - Global Forecast to 2029
The global market for the AI in chemicals market is projected to reach USD 3.8 billion by 2029 at a CAGR of 39.2% during the forecast period. The major AI in chemicals providers include IBM (US), Microsoft (US), Schneider Electric (France), AWS (US), Google (US), SAP (Germany), NVIDIA (US), C3.ai (US), GE Vernova (US), Siemens (Germany), Hexagon (Sweden), Engie Impact (US), TrendMiner (Belgium), Xylem (US), NobleAI (US), Iktos (France), Kebotix (US), Uptime AI (US), Canvass AI (Canada), Nexocode (Poland), SandboxAQ (US), Deepmatter (England), Zapata AI (US), Citirne Informatics (US), Chemical.AI (China), Augury (Israel), Intellegens (UK), Ripik.AI (India), Tractian (US), Polymerize (Singapore), ScienceDesk (Germany), OptiSol Business Solutions (India), NuWater (Africa) and VROC (Australia). These companies have used both organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the AI in chemicals market.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Patient Simulation Market by Offering (High-fidelity Simulator, Software, Web-based), Technology (AI-integrated), Age (Pediatric, Adults), Indication (Respiratory, Emergency, Cardio), End User (Academic Institutes, Hospital) - Global Forecast to 2030
The Patient Simulation market, valued at USD 1.32 billion in 2024, stood at USD 1.54 billion in 2025 and is projected to advance at a resilient CAGR of 16.0% from 2025 to 2030, culminating in a forecasted valuation of USD 3.23 billion by the end of the period. The patient simulation market is experiencing steady growth as healthcare systems increasingly focus on structured clinical training and reducing errors.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Military Simulation (Ground, Air & Naval Based Simulation) Market, By Products, Technology, Application & Geography - 2019
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Medical Simulation Market by Offering [Anatomical Models {Patient (High Fidelity), Surgical (Laparoscopic, Ortho, Gynae, Spine), Trainers}, Software], Technology [3D Printing, Virtual Patient, Procedural Rehearsal], End User - Forecast to 2030
The Asia Pacific medical simulation market, valued at USD 0.68 billion in 2024, stood at USD 0.80 billion in 2025 and is projected to advance at a resilient CAGR of 17.0% from 2025 to 2030, culminating in a forecasted valuation of USD 1.74 billion by the end of the period. The Asia Pacific medical simulation market is growing, driven by increasing healthcare spending, rising demand for skilled healthcare professionals, and expanding adoption of simulation-based training technologies in medical education and clinical practice.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Education Market by Provider (Universities, Educational Platforms, Medical Simulation), Delivery Mode (Classroom-based, E-Learning), Application (Neurology, Cardiology, Pediatrics), End User (Students, Physicians) - Global Forecasts to 2028
The global healthcare education market, valued at US$101.1 billion in 2022, stood at US$108.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2025 to 2028, culminating in a forecasted valuation of US$164.6 billion by the end of the period. The healthcare education solutions market's growth is driven by technological advancements, the focus on patient safety and quality care, the shortage of healthcare professionals, and the impact of the COVID-19 pandemic.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Medical Training Simulation Market by Offering (Anatomical Models [Patient (High Fidelity)], [Surgical (Laparoscopic, Ortho, Gynae)], Software), Technology (3D Printing, Virtual Patient), Training Type (Emergency & Trauma), End User - Global Forecast 2030
The global medical training simulation market is projected to reach USD 4.48 billion by 2030, growing at a CAGR of 12.3% during the forecast period (2025–2030). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Europe Medical Simulation Market by Offering (Anatomical Models [Patient (High Fidelity), Surgical (Laparoscopic, Ortho, Gynae, Spine), Trainers, Ultrasound, Eye]), Technology (3D Printing, Virtual Patient, Procedural Rehearsal), End User - Forecast 2030
The Europe Medical Simulation market, valued at USD 0.85 billion in 2024, stood at USD 0.99 billion in 2025 and is projected to advance at a resilient CAGR of 15.9% from 2025 to 2030, culminating in a forecasted valuation of USD 2.06 billion by the end of the period. The Europe healthcare simulation market is growing steadily, driven by a strong emphasis on patient safety, standardized medical training, and widespread adoption of simulation-based education across hospitals and academic institutions (Karolinska Institutet, Imperial College London, etc.).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Medical Simulation Market by offering (Anatomical Models [Patient {High Fidelity}, Surgical {Laparoscopic, Ortho, Gynec, Spine}, Trainers, Ultrasound], Software), Technology (3D Printing, Virtual Patient, Procedural Rehearsal), End User - Forecast 2030
The US Medical Simulation market, valued at USD 1.20 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2030, culminating in a forecasted valuation of USD 2.83 billion by the end of the period. The US medical simulation market continues to expand, supported by rising demand for advanced clinical training, stricter regulatory and accreditation requirements, and a growing healthcare workforce.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
